Jure Kozuh`s Blog

Studies carried out in the UK involving the experimental drug Abiraterone, which targets an enzyme necessary for the production of testosterone and thus prevents the production of testosterone within the body, have shown promising results when it comes to advanced prostate cancer treatment. Testosterone fuels prostate cancer growth and to many people’s surprise is not only produced within the testes but is also produced in other areas of the body, including the adrenal glands. By preventing the production of testosterone throughout the body Abirsterone cuts off a prostate cancer’s fuel supply causing psa levels to fall significantly and also shrinking tumors which in many cases have failed to respond to other forms of treatment.